Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Ceftriaxone/Cefuroxime in Community-Acquired Pneumonia
NCT00257049Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 1984
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of levofloxacin in community acquired pneumonia (CAP) (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Clinical response rate. Started Jan 1984; status: completed.
02
Drugs
levofloxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00257049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257049.